The impact of COVID-19 on plastic and reconstructive surgery in China: A single-centre retrospective study

Qiao, Zhihua; Deng, Yiwen; Wang, Xiancheng; Sun, Yang; Xiong, Xiang; Meng, Xianxi; Li, Wenbo; Yi, Zhongjie; Li, Xiaofang; Bao, Fangyin

doi:10.1016/j.bjps.2022.10.033

Cited by 4 publications

(3 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…32,33 These guides were similarly followed outside the United States, with studies showing a decrease in plastic surgery cases in the initial months of the pandemic in other countries. 34,35 Despite the novelty of the SARS-CoV-2 viral pandemic, experts estimated the disruption of the health care system to last around 12 weeks. 10 In actuality, plastic surgeons reported that, on average, they stopped performing procedures for 8.1 weeks, a third less than projected, even when considering the numerous viral surges that were anticipated in the first year after the start of the pandemic.…”

Section: Discussionmentioning

confidence: 99%

“…The American Society of Plastic Surgeons recommended the postponement of all reduction mammaplasties along with a number of other aesthetic/reconstructive surgeries guided by a surgery acuity scale 32,33 . These guides were similarly followed outside the United States, with studies showing a decrease in plastic surgery cases in the initial months of the pandemic in other countries 34,35 . Despite the novelty of the SARS-CoV-2 viral pandemic, experts estimated the disruption of the health care system to last around 12 weeks 10 .…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Shifts in Reduction Mammaplasty Surgical Volumes With the Emergence of a Global Pandemic

Shah,

Navarro,

Thawanyarat

et al. 2024

Ann Plast Surg

View full text Add to dashboard Cite

Introduction The onset of the COVID-19 pandemic resulted in significant changes to the surgical caseload for various surgery departments across the United States. As medical institutions prioritized resources for the expected increase in patient volumes due to the SARS-CoV-2 viral infection, surgical departments saw a decrease in nonemergent and elective surgical procedures. Reduction mammoplasties, which are largely covered by insurance, are among the elective procedures that provide significant revenue to the hospital. This expected decline in procedures suggests a potential decline in revenue provided by the plastic surgery department of a hospital. The purpose of this study was to analyze the loss of revenue experienced by a single academic medical institution due to changes in breast reduction mammoplasty volumes during the COVID-19 pandemic. Methods Upon institutional review board approval, using the Augusta University Medical Center's Financial Billing Data, 373 patients who underwent bilateral reduction mammoplasty were queried. A time horizon of March 2019 to February 2022 was used to determine the pre- and post-COVID case load and charges that were incurred. Statistical analysis to compare the prior 12 months and after 24 months of COVID was conducted using 2 samples of equal variance t test and F test confirming equal variance. Results There was a statistically significant increase in the number of reduction mammoplasties performed per month from the year before the onset of COVID-19 (March 2020) to the 2 years after (6.6–11.4 per month, P = 0.0024). There was a statistically significant increase in the per-month charges from the AU Health system for reduction mammoplasties for the same period ($31,780.92–$52,113.34 per month, P = 0.0054). Although there was an increase in per-month revenue from reduction mammoplasties, this increase failed to reach statistical significance ($7,059.95–$10,423.51 per month, P = 0.064). Conclusions The plastic surgery department saw a statistically significant increase in reduction mammoplasty cases and subsequent charges in the post-COVID cohort. These findings suggest that the emergence of a nationwide pandemic did not necessarily lead to a decrease in the volume of nonemergent surgical cases despite an expected decrease in caseload due to the need to reallocate hospital resources. On the contrary, there was an increase in caseload suggesting that there may be other factors contributing to patients' pursuance of reduction mammoplasty post-COVID including convenience, resulting from time off due to pandemic, meeting insurance-covered reduction criteria, and projected recovery time.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Shifts in Reduction Mammaplasty Surgical Volumes With the Emergence of a Global Pandemic

Shah,

Navarro,

Thawanyarat

et al. 2024

Ann Plast Surg

View full text Add to dashboard Cite

show abstract

“…This equates to an increase of 33.3% over the last 4 years [1]. Paradoxically, the COVID-19 pandemic has increased plastic surgery procedures around the world; although the frequency of scheduled plastic surgery has apparently decreased in many countries, some procedures have increased as patients have free time for their cosmetic plans [2][3][4][5]. The top five most popular surgical procedures remain liposuction, breast augmentation, eyelid surgery, rhinoplasty, and abdominoplasty [1].…”

Section: Introductionmentioning

confidence: 99%

Postoperative Analgesia in Plastic Surgery Procedures

Arévalo-Villa,

Figueroa Morales,

de Jesús Jiménez-Contreras

et al. 2023

Topics in Postoperative Pain

View full text Add to dashboard Cite

Advances in the knowledge of the secondary effects of acute postoperative pain have motivated anesthesiologists and surgeons to pay special attention to its prevention and correct management. Surgical procedures in plastic surgery are very varied and produce postoperative pain in direct relation to the site, type, and extent of surgery, with facial interventions being the least painful (with the exception of rhinoplasty) and the most painful being breast surgery, abdominoplasty, and extensive liposuctions due to the possibility of trauma to peripheral nerves and greater secondary inflammation. The combination of surgeries produces more intense post-surgical pain. There is insufficient data on the frequency and severity of pain after plastic surgery, be it reconstructive or cosmetic. Although opioids have been considered to be the cornerstone in the treatment of postsurgical pain, their use in plastic surgery patients must be carefully evaluated for various reasons that interfere with the results of this type of surgery. Similar to other surgical specialties, multimodal analgesia is now the most appropriate way to prevent and treat pain in these patients. This chapter is a comprehensive review of the management of acute postoperative pain in certain plastic surgery procedures, with emphasis on the multimodal approach.

show abstract

A Bibliometric Analysis of the Articles Published in the Aesthetic Plastic Surgery Journal (1976–2023)

Bai,

Chen

2024

Aesth Plast Surg

View full text Add to dashboard Cite

The impact of COVID-19 on plastic and reconstructive surgery in China: A single-centre retrospective study

Cited by 4 publications

References 30 publications

Shifts in Reduction Mammaplasty Surgical Volumes With the Emergence of a Global Pandemic

Shifts in Reduction Mammaplasty Surgical Volumes With the Emergence of a Global Pandemic

Postoperative Analgesia in Plastic Surgery Procedures

A Bibliometric Analysis of the Articles Published in the Aesthetic Plastic Surgery Journal (1976–2023)

Contact Info

Product

Resources

About